Skip to search formSkip to main contentSkip to account menu

etoricoxib

Known as: 5-chloro-2-(6-Methylpyridin-3-yl)-3-(4-(methylsulfonyl)phenyl)pyridine, 5-Chloro-3-(4-methanesulfonyl-phenyl)-6'-methyl-[2,3']bipyridinyl, 5-chloro-6'-Methyl-3-(P-(methylsulfonyl)phenyl)-2,3'-bipyridine 
A synthetic, nonsteroidal anti-inflammatory drug (NSAID) with antipyretic, analgesic, and potential antineoplastic properties. Etoricoxib… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
BACKGROUND AND PURPOSE Deletion of the cyclooxygenase‐2 (COX‐2) gene causes impairment of kidney development, but the effect of… 
2010
2010
A new, simple HPTLC method for determination of etoricoxib (ETO) and thiocolchicoside (THIO) in combined tablet dosage form has… 
2008
2008
Summary Dysmenorrhoea is painful menstruation that occurs in 45–72% of all women. This was a prospective randomised study of the… 
2007
2007
Background:  Arthroscopic shoulder surgery under general anaesthesia is often associated with severe post‐operative pain which… 
2007
2007
This multicenter, double‐blind, randomized, placebo‐controlled, parallel‐group study assessed renal function during dosing with… 
Highly Cited
2005
Highly Cited
2005
BACKGROUND The purpose of the present study was to evaluate the effect of a potent selective cyclooxygenase-2 (COX-2) inhibitor… 
2005
2005
ABSTRACT Background: To compare the analgesic effect of single doses of etoricoxib 120 mg, oxycodone/acetaminophen 10 mg/650 mg… 
2004
2004
To investigate the influence of modifying in vivo cytochrome P450 3A (CYP3A) activity on the pharmacokinetics of etoricoxib, a…